| |
Latest 10 SEC filings (by transaction date) for INSM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 29/24 | Feb 28/24 | Lewis William | Indirect Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | 50,000 | |
Feb 29/24 | Feb 28/24 | Lewis William | Indirect Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 50,000 | $12.58 |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Indirect Ownership | Common Stock | G - Gift | 1,200 | |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Indirect Ownership | Common Stock | G - Gift | 1,200 | |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Indirect Ownership | Common Stock | G - Gift | 1,200 | |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Direct Ownership | Common Stock | G - Gift | -3,600 | |
Jan 12/24 | Jan 12/24 | Flammer Martina M.D. | Direct Ownership | Common Stock | S - Open market or private sale | -4,667 | $28.63 |
Jan 12/24 | Jan 12/24 | Adsett Roger | Direct Ownership | Common Stock | S - Open market or private sale | -5,251 | $28.63 |
Jan 11/24 | Jan 10/24 | Flammer Martina M.D. | Direct Ownership | Common Stock | S - Open market or private sale | -1,245 | $28.90 |
Jan 11/24 | Jan 10/24 | Adsett Roger | Direct Ownership | Common Stock | S - Open market or private sale | -3,536 | $28.90 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for INSM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 29/24 | Feb 28/24 | Lewis William | Indirect Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | 50,000 | |
Feb 29/24 | Feb 28/24 | Lewis William | Indirect Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 50,000 | $12.58 |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Indirect Ownership | Common Stock | G - Gift | 1,200 | |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Indirect Ownership | Common Stock | G - Gift | 1,200 | |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Indirect Ownership | Common Stock | G - Gift | 1,200 | |
Feb 29/24 | Feb 28/24 | Sharoky Melvin Md | Direct Ownership | Common Stock | G - Gift | -3,600 | |
Jan 12/24 | Jan 12/24 | Flammer Martina M.D. | Direct Ownership | Common Stock | S - Open market or private sale | -4,667 | $28.63 |
Jan 12/24 | Jan 12/24 | Adsett Roger | Direct Ownership | Common Stock | S - Open market or private sale | -5,251 | $28.63 |
Jan 11/24 | Jan 9/24 | Wise John Drayton | Direct Ownership | Common Stock | S - Open market or private sale | -1,861 | $28.78 |
Jan 11/24 | Jan 9/24 | Smith Michael Alexander | Direct Ownership | Common Stock | S - Open market or private sale | -2,373 | $28.76 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |